OncoSil Medical Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €289.40K +40.5% -€6.67M +5.0% -2,306.1% +7.8 pp -€5.95M -5.6% -2,057.0% +10 pp
    €205.96K +58.6% -€6.35M +5.7% -3,085.0% +15 pp -€6.31M +11.4% -3,061.9% +13 pp
    €129.84K +8.8% -€6.01M +2.8% -4,627.9% +2.7 pp -€5.66M +15.3% -4,359.3% -2.5 pp
    €119.35K -92.3% -€5.84M +144.8% -4,897.0% -47 pp -€4.91M +97.5% -4,112.0% -40 pp
    €1.55M -23.8% -€2.39M -50.3% -154.2% +0.82 pp -€2.48M -40.8% -160.5% +0.46 pp
    €2.03M -18.5% -€4.80M +0.3% -236.3% -0.44 pp -€4.19M -10.7% -206.5% -0.18 pp
    €2.49M +26.6% -€4.78M +21.7% -192.0% +0.077 pp -€4.70M +38.5% -188.5% -0.16 pp
    €1.97M -8.4% -€3.93M +47.1% -199.7% -0.75 pp -€3.39M +34.2% -172.4% -0.55 pp
    €2.15M +39.2% -€2.67M +65.6% -124.3% -0.20 pp -€2.53M +3,484.5% -117.7% -1.1 pp
    €1.54M +772.9% -€1.61M -58.1% -104.4% +21 pp -€70.55K -98.0% -4.6% +20 pp
    €176.93K +∞% -€3.85M +681.0% -2,173.5% -22 pp -€3.56M +1,615.2% -2,011.7% -20 pp
    €0.00 +NaN% -€492.38K +103.9% N/A -€207.52K +22.1% N/A
    €0.00 +NaN% -€241.43K -70.4% N/A -€169.94K -4.2% N/A
    €0.00 -100.0% -€816.72K -14.8% N/A -€177.38K -271.3% N/A
    €1.17M -9.4% -€959.01K +289.1% -82.0% -0.63 pp €103.53K -604.6% 8.9% +0.10 pp
    €1.29M +11.6% -€246.47K -84.1% -19.1% +1.1 pp -€20.52K -98.3% -1.6% +1.0 pp
    €1.16M +17.4% -€1.55M +65.3% -134.1% -0.39 pp -€1.20M +94.4% -103.9% -0.41 pp
    €984.76K +16.3% -€937.71K +1,207.8% -95.2% -0.87 pp -€618.18K -336.5% -62.8% -0.94 pp
    €846.96K +∞% -€71.70K +384.5% -8.5% -0.085 pp €261.38K -3,142.8% 30.9% +0.31 pp
    €0.00 -€14.80K N/A -€8.59K N/A

    Notifications